Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q3 2015 · 10-Q
Revenue$1.25M$1.25M+96.8% vs Q3 2014 Net Income-$245.40K-$245.40KN/M vs Q3 2014 EPS Diluted-$0.13-$0.13— vs Q3 2014 Operating Income-$1,927,017N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,667,872N/M Margins · derivedOperating margin-154.6%+258.9 pt vs Q3 2014
Net margin-19.7%+556.3 pt vs Q3 2014
ended Sep 30, 2015 · filed Nov 13, 2015 · 44 d after period end